Cipher, Ranbaxy Settle Patent Dispute with Actavis over Absorica - 06.10.2015

Cipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litigation settlement with Actavis over generic version of Absorica, a drug used to treat acne.

Tags : Cipher Ranbaxy Absorica patent

Share :